IP Library Granted Patent US 11,903,954
Granted Patent B2
US 11,903,954 · App. 17/879,267 · Granted Feb 20, 2024

Method of treating urolithiasis

Inventors: Daniel J. Laser (San Francisco, CA); Alice Luong (San Francisco, CA); Robert G. Miotke (Gold River, CA)
Assignee: APPLAUD MEDICAL, INC.
A61K31/685A61K9/0034A61K9/167A61K9/5015A61K9/5089A61K41/0028A61K47/06A61K47/26A61K47/32A61K47/544A61K47/60A61K47/6925A61P13/04C07F9/3873C07F9/405A61K31/663
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,903,954
App. No.
17/879,267
Granted
Feb 20, 2024
Kind
B2
Abstract

The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.

Claims (34)

1. A method of treating an abnormal or obstructive mass, the method comprising:

administering to a subject with the abnormal or obstructive mass an effective amount of a microsphere composition comprising microspheres containing fluid, so as to bring the microspheres into contact with the abnormal or obstructive mass within the subject, and

directionally applying an energy to the abnormal or obstructive mass at a frequency that excites the fluid within the microspheres;

wherein the microsphere composition comprises:

a compound of Formula I

or a salt, isomer, or salt of an isomer thereof;

wherein:

n is from 10 to 30;

m is from 1 to 100; and

X is selected from the group consisting of: hydrogen, silyl, acyl, aminoacyl, thioacyl, aminocarbonyl, aminoacyl carbonyloxy, aminothiocarbonyl, aminosulfonyl, amidino, substituted sulfonyl, substituted sulfinyl, carboxy ester, phthalimido, OH, SO 3 H and PO 3 H; and

a pharmaceutically acceptable excipient, wherein the abnormal or obstructive mass is a urinary stone or a kidney stone.

2. The method of claim 1 , wherein the microsphere composition is a reconstituted microsphere solution.

3. The method of claim 2 , wherein the reconstituted microsphere solution is administered into a ureter of the subject through a urinary catheter.

4. The method of claim 1 , wherein the energy is in a form of ultrasonic, electromagnetic, acoustic, microwave, laser or photonic energy.

5. The method of claim 4 , wherein the energy is ultrasonic.

6. The method of claim 5 , wherein the ultrasonic energy is in a frequency range from 100 kilohertz (kHz) to 2 megahertz (MHz).

7. The method of claim 5 , wherein the ultrasonic energy is associated with peak pressures in a range from 0.1 MPa to 10 MPa.

8. The method of claim 1 , wherein the energy is applied for a sufficient amount of time to fragment the abnormal or obstructive mass.

9. The method of claim 8 , wherein the amount of time is no more than 100 minutes, no more than 90 minutes, no more than 80 minutes, more than 70 minutes, no more than 60 minutes, no more than 50 minutes, no more than 40 minutes, no more than 30 minutes, no more than 25 minutes, no more than 20 minutes, no more than 15 minutes, or no more than 10 minutes.

10. The method of claim 1 , wherein the applied energy causes a change in volume of the microspheres or causes other cavitation effects of the microspheres.

11. The method of claim 10 , wherein the cavitation of the microspheres causes pressure gradient changes and other mechanical effects in the abnormal or obstructive mass around the microspheres.

12. The method of claim 1 , wherein the applied energy causes fragmentation of the abnormal or obstructive mass.

13. The method of claim 1 , wherein the subject is human.

14. The method of claim 1 , wherein the microsphere composition further comprises:

i. a compound of Formula II

or a salt, isomer, or salt of an isomer thereof; and

ii. a compound of Formula III

or a salt, isomer, or salt of an isomer thereof;

wherein:

t is from 10 to 30;

y is from 1 to 100; and

z is from 10 to 30.

15. The method of claim 1 , wherein the abnormal or obstructive mass is a urinary stone.

16. The method of claim 1 , wherein the energy is in a form of laser.

Assignments (3)
CHANGE OF NAME Recorded Jul 11, 2024
From: APPLAUD MEDICAL, INC.
To: AVVIO MEDICAL, INC.
Reel/Frame 068294/0515 →
CORRECTION OF THE APPLICATION NUMBER, REEL 064489, FRAME 0032 Recorded Oct 2, 2023
From: LASER, DANIEL J.; LUONG, ALICE; MIOTKE, ROBERT G.
To: APPLAUD MEDICAL, INC.
Reel/Frame 065094/0708 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2023
From: LASER, DANIEL J.; LUONG, ALICE; MIOTKE, ROBERT G.
To: APPLAUD MEDICAL, INC.
Reel/Frame 064489/0032 →
Continuity (3)
Continuation 17155537 · Jan 22, 2021
Continuation 16775253 · Jan 28, 2020
Related Publication 20220395517A1 · Dec 15, 2022